Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dividend Distribution
confidence 98%
filed 2026-08-31
Item 8.01
The filing discloses a declared distribution of $0.1800 per share (comprising $0.1600 regular monthly distribution plus $0.0200 special distribution) across six classes of common stock, payable on or about September 15, 2026. This is a routine but material dividend declaration by a real estate finance trust, directly matching the dividend_distribution event type.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-31
Item 5.02
Gregory W. Haskell departed as Chief Executive Officer and director, effective September 1, 2026. His retirement was not the result of any disagreement and includes a consulting arrangement transition.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-31
Item 7.01
The Company underwent significant board restructuring and leadership transitions: Bruce Brown appointed as independent Chairman (succeeding Michael Otworth), Catriona Fallon named Audit Committee Chair, Dr. William Grieco assuming CEO role effective September 1, 2026 (accelerated from October 1), and Suzanne Niemeyer resigned from the Board. These changes were designed to enhance independence and accountability.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-08-31
Item 8.01
A putative securities class action complaint (Labed v. Innventure, Inc., Case No. 1:26-cv-07377) was filed August 28, 2026 in the U.S. District Court for the Southern District of New York against the Company and certain executive officers, alleging materially false and misleading statements under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5, and seeking unspecified compensatory damages.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-08-28
Item 5.02
Anne Bramman, a Board member and Chair of the Audit Committee, has informed the Board of her intention to resign effective November 30, 2026, due to her appointment as Executive Vice President and Chief Financial Officer of Best Buy Co., Inc. The departure of an Audit Committee chair is material to investors as it affects governance and oversight structure. While a successor (Valarie Sheppard) has been identified, the loss of an experienced audit committee leader represents a material change in the registrant's governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-28
Item 5.07
This Item 5.07 discloses the results of AIR T's 2026 Annual Meeting of Stockholders held on August 25, 2026, with detailed voting tallies for three proposals: election of five directors (all passed with strong support), an advisory vote to approve named executive officer compensation (passed with 2,180,386 votes for), and ratification of Deloitte & Touche LLP as independent auditor (passed with 2,481,936 votes for). The disclosure is a textbook shareholder vote results filing.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-28
Item 8.01
First Keystone Corporation announced the redemption of $25,000,000 in outstanding 4.375% Fixed to Floating Rate Notes due December 31, 2030, at par plus accrued interest on September 30, 2026. This is a material financial event involving the early retirement of a significant debt obligation, but it does not fit the specific categories of debt_issuance (which concerns creation of new obligations), covenant_breach, or other named financial event types. The redemption at par is a routine debt management action that would affect investor assessment of the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
Steven W. Presley was elected to Altria's Board of Directors effective August 27, 2026, and appointed to three Board committees: Compensation and Talent Development, Innovation, and Finance. Presley is the CEO of Refresco Benelux and former senior executive at Nestlé.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-08-28
Item 8.01
This Item 8.01 discloses settlement of a putative stockholder derivative and class action lawsuit alleging breaches of fiduciary duty by JBS (majority stockholder) and company directors regarding a Charter Amendment and Tax Sharing Agreement. The settlement requires a $31 million cash payment from JBS Defendants to the Company, subject to Delaware Court of Chancery approval. This is a material litigation settlement that would affect a reasonable investor's assessment of the company's legal exposure and financial position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-08-28
Item 2.03
Deckers entered into a First Amendment to its Credit Agreement on August 27, 2026, increasing the unsecured revolving credit facility commitments to $500 million and extending the maturity date to August 27, 2031. This material modification increases available borrowing capacity and extends the term of the Company's direct financial obligations.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-28
Item 7.01
The Board authorized a share repurchase program of up to 5.0 million shares for fiscal year 2027, which is a form of capital return to shareholders. Share repurchases are classified as dividend_distribution events under the taxonomy, as they represent a return of capital to security holders alongside regular dividends and special distributions.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-28
The 6-K body explicitly states that "Attached hereto as Exhibit 1 is a copy of the press release issued by Frontline plc on August 28, 2026, reporting the Company's results for the second quarter and six months ended June 30, 2026." This is a discrete earnings announcement for Q2 and H1 2026 results, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-08-28
Item 1.01
EFCAR and Exeter Finance LLC entered into an Underwriting Agreement on August 26, 2026, for the issuance of approximately $961 million in aggregate principal amount of asset-backed notes across eight classes by Exeter Automobile Receivables Trust 2026-4, with closing expected August 31, 2026. The filing also discloses execution of multiple agreements related to the securitization transaction involving transfer of sub-prime automobile loan receivables and issuance of notes backed by those receivables.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-28
Item 3.02
The Company issued approximately 3.25 million common shares for $80.6 million in an unregistered offering pursuant to Section 4(a)(2) and Regulation D to accredited investors, resulting in dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-08-28
Item 7.01
The Company disclosed its portfolio composition and investment metrics as of July 31, 2026, including 62 portfolio companies with $1,469 million par value, weighted average net leverage of 5.0x, weighted average yield of 9.4%, and total platform size of $4.9 billion.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-28
Item 8.01
The Company declared a distribution of approximately $0.22 per share to shareholders of record as of August 31, 2026, payable on or about September 28, 2026, with aggregate NAV of $742 million ($24.80 per Common Share) as of July 31, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-28
Item 3.02
The Company issued approximately 209,520 common shares for $5.2 million (~$24.64 per share) to accredited investors pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-28
Item 8.01
The Company declared a distribution of approximately $0.19 per share to shareholders of record as of August 31, 2026, payable on September 28, 2026, with NAV as of July 31, 2026 at $24.64 per Common Share.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-28
Item 7.01
The filing discloses portfolio composition and performance metrics as of July 31, 2026, including median EBITDA of $96 million, weighted average net leverage of 5.0x, and weighted average yield of 9.3%, providing material information about the fund's investment portfolio and platform size.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-28
Item 5.07
This Item 5.07 disclosure reports the final vote results from Ballston Spa Bancorp's Annual Meeting of Shareholders held on August 27, 2026. The filing presents voting tallies for the election of seven directors (Paul N. DiCaprio, Michael S. Dunn, Beth A. Grasso, Aaron P. Flach, Joseph H. Warren, Carl A. Florio, and Donald G. Persico) and the ratification of Crowe LLP as independent auditor, with specific vote counts for each matter. This is a routine but material shareholder governance event required to be disclosed under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-28
Socket Mobile received a Notice from Nasdaq on August 24, 2026, stating it no longer complies with Nasdaq Listing Rule 5550(b)(1) requiring minimum stockholders' equity of $2.5 million; the Company reported only $2,382,624 in stockholders' equity as of June 30, 2026. The Company has 45 calendar days to submit a compliance plan and faces potential delisting if it cannot regain compliance. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-08-28
ICICI Bank completed issuance of USD 1 billion Senior Unsecured Fixed Rate Notes under its USD 7.5 billion Global Medium Term Note Programme. This is a material creation of a direct financial obligation through debt issuance, rated BBB by S&P and Baa3 by Moody's, and listed on multiple exchanges. The announcement explicitly states completion of the issuance, making this a discrete debt-issuance event material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-28
Item 8.01
Norwood Financial Corp announced authorization of a stock repurchase program for up to 550,000 shares (approximately 5% of outstanding shares). Stock repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" alongside dividends and distributions. The program is material as it represents a significant capital allocation decision affecting shareholder value.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-28
Item 5.07
Shareholders approved a merger with Altaris LLC affiliates at a Special Meeting held on August 27, 2026, with 14,735,712 votes in favor. The meeting also approved advisory compensation arrangements related to the merger and potential adjournment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-28
Item 8.01
The filing provides an update on the pending merger with Altaris LLC affiliates, noting that closing remains subject to satisfaction of customary conditions including receipt of regulatory approvals in France, with extensive discussion of merger-related risks, expected timing, and benefits.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-08-28
The company announces its decision to exercise an option to redeem in full the outstanding Series XLIX Notes due September 2, 2027, with redemption scheduled for September 4, 2026 at 100% of principal plus accrued interest. While this is technically a redemption (debt retirement) rather than a new issuance, it represents a material modification of the company's direct financial obligations and capital structure. The redemption is a significant financial event affecting the registrant's debt profile and would be material to investors assessing the company's financial position.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 95%
filed 2026-08-28
The 6-K discloses the resignation of De Visser Gray LLP as the Company's independent registered public accounting firm effective August 24, 2026, and the concurrent engagement of MNP LLP as the new auditor. The filing explicitly addresses the change in certifying accountant under Item 16F of Form 20-F, confirming no disagreements or reportable events preceded the change. This is a classic auditor change event material to investors assessing audit quality and financial reporting oversight.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-28
Item 2.01
Energy Fuels Inc. completed the acquisition of all ordinary shares of Australian Strategic Materials Limited (ASM) on August 28, 2026, pursuant to a Scheme Implementation Deed, for total consideration of approximately US$243.4 million in combined share and cash consideration.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-08-28
EX-99.1
Zentek received notice from Nasdaq that its common shares will be delisted from the Nasdaq Capital Market due to non-compliance with the minimum bid price requirement, effective September 2, 2026. The company's shares will transition to OTC Markets Group trading. This is a material delisting event that directly affects the registrant's listing status and market accessibility, even though the primary listing on TSX Venture Exchange remains unaffected.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-28
Item 5.02
The disclosure centers on a Consulting Services Agreement with Darren R. Yeates, the Executive Vice President and Chief Operating Officer, establishing compensatory arrangements including a minimum monthly consulting fee of $89,773, hourly rates for excess services, and severance-like protections (unpaid fees through January 31, 2028 if terminated without cause or due to death/disability). While the agreement follows his employment contract expiration, the principal disclosed action is the arrangement of compensation terms, not a departure or appointment, making this an exec_compensation event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-28
Item 1.01
PTC Therapeutics entered into an asset purchase agreement with Sangamo Therapeutics to acquire ST-920, an AAV gene therapy product candidate for Fabry disease, for $111 million upfront plus up to $100 million in contingent milestone payments. This is a material acquisition of assets disclosed under Item 1.01, involving a significant financial commitment and strategic addition to the company's pipeline. The transaction is subject to Bankruptcy Court approval scheduled for September 10, 2026.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 99%
filed 2026-08-28
Item 1.03
BioXcel Therapeutics and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on August 27, 2026, in the U.S. Bankruptcy Court for the District of Delaware. The company will operate as debtors-in-possession and has filed for debtor-in-possession financing.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-28
EX-99.1
BW LPG announced Q2 2026 financial results with net profit after tax of US$138 million and earnings per share of US$0.79, accompanied by detailed financial performance metrics and forward guidance.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-08-28
EX-99.4
BW LPG's Board approved a cash dividend of US$0.95 per share (NOK 8.8914 for Oslo-listed shares) for Q2 2026, with record date 8 September 2026 and payment date on or about 16 September 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-08-28
Item 5.02
Rhonda M. Taylor, Executive Vice President and General Counsel, announced her retirement effective December 7, 2026, after 26 years of service. Taylor oversaw legal, compliance, audit, risk, and government affairs functions. Kelly Collier was appointed as her successor.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-28
EX-99.1
This exhibit is a press release announcing Chagee's unaudited financial results for the second quarter ended June 30, 2026. It discloses quarterly net revenues (RMB3,414.6 million), operating income, net income, and earnings per share, along with detailed operational metrics and balance sheet data. The document explicitly states "Chagee Announces Second Quarter 2026 Unaudited Financial Results" and includes a conference call notice, making it a classic earnings release. Material to investors as it reports quarterly financial performance and operational trends.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-28
EX-99.1
This exhibit discloses the poll results of an Extraordinary General Meeting held on August 28, 2026, where shareholders voted on approval of a Revised Supply of Products Framework Agreement with Sharpa and a revised annual cap. The announcement reports voting tallies by share class, quorum details, and confirmation that the ordinary resolution passed with 99.98% of votes cast in favor. This is a classic shareholder vote result disclosure under Item 5.07 equivalent, and the approval of a material supply framework agreement makes it material to investors.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-08-28
EX-99.1
NetEase announced a grant of 224,739 Awards (1,123,695 underlying shares) to employee participants under the 2019 Share Incentive Plan on August 28, 2026. The disclosure details the vesting schedule (three annual installments from 2027–2029), performance conditions tied to individual evaluations, purchase price (nil), and clawback provisions. This is a material compensatory arrangement for employees under an equity incentive plan, fitting the exec_compensation category as a disclosure of equity grants to eligible participants.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-08-28
EX-99.1
This announcement discloses the grant of 852,000 restricted share unit (RSU) awards under the 2022 share incentive plan to directors and employees, including 174,000 RSUs to Mr. Vincent Wenbin Qiu (CEO and director) and 18,000 RSUs to Ms. Bin Yu (director). The disclosure details vesting schedules, performance conditions, and clawback mechanisms, and explicitly states that the RSU grants to directors form part of their remuneration packages. This is a compensatory arrangement for named executives and directors requiring board approval, fitting the exec_compensation category.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-28
Item 8.01
The Board of Trustees declared a distribution of $0.21 per Common Share for August 2026, payable on September 20, 2026. This is a routine but material dividend distribution to shareholders, typical for closed-end funds like Stone Point Credit Income Fund. The disclosure includes record date, payment date, and per-share amount, and notes that distributions may be reinvested under the fund's DRIP.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-28
Item 1.01
Quoin entered into a Securities Purchase Agreement on August 27, 2026, for a private placement of up to $50.0 million in gross proceeds, consisting of 6,305,300 ADSs (or pre-funded warrants) and accompanying ordinary warrants to purchase 3,152,650 ADSs. The unregistered equity issuance under Section 4(a)(2) and Regulation D exemptions is structured as a PIPE-like transaction with insider participation, representing significant dilution to existing shareholders and expected to fund operations into the second half of 2029.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-28
Item 8.01
Quoin announced positive interim clinical trial results from the Phase 2/3 study CL-QRX003-004 of QRX003 for Netherton Syndrome, with the primary endpoint met with statistical significance (p=0.0087 vs. α=0.0215) in 4 of 6 participants. This material clinical milestone represents a significant development in the company's late-stage specialty pharmaceutical pipeline.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-28
The 6-K discloses results of the Company's 2026 annual general meeting held on August 28, 2026, including voting outcomes for the re-election of three independent directors (Marie Holive, Andrew Sheppard, and Tal Shoham) and approval of Amended and Restated Memorandum and Articles of Association. This is a classic shareholder vote results disclosure. The election of directors and approval of amended bylaws are material governance matters affecting the composition of the board and the company's governing documents.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-08-28
Item 1.01
Rainier Acquisition Corp entered into multiple material definitive agreements in connection with its initial public offering, including an Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and Private Placement Unit Purchase Agreement, establishing the SPAC's formation and framework for future business combination activities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-28
Item 3.02
Rainier Acquisition Corp completed a private placement of 194,375 Private Placement Units at $10.00 per unit (totaling approximately $1.94 million) simultaneously with its IPO on August 28, 2026, with units issued as unregistered securities under Section 4(a)(2) exemption and restricted transferability until 30 days after the initial business combination.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-28
Item 5.02
On August 26, 2026, Wing C. ('Andrew') Lam, PharmD and Chidozie Ugwumba were appointed to the board of directors in connection with the effectiveness of the Registration Statement for the Company's IPO, with assignments to board committees.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-28
Item 8.01
Rainier Acquisition Corp announced the pricing of its $75 million initial public offering on August 26, 2026 and the closing of the IPO on August 28, 2026, with press releases disclosing the capital raise and IPO terms.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-28
EX-99.1
Ms. Tianjing Zhang was appointed as an independent director effective August 29, 2026, and Mr. David Zhang was re-designated as an independent director under Hong Kong Listing Rules. These board composition changes affecting independent director status are material governance events.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-28
Item 5.02
The disclosure reports approval by the compensation committee of one-time cash bonus payments to four named executive officers (CEO Tamir Poleg, CFO Ravi Jani, President Jenna Rozenblat, and CTO Pritesh Damani) totaling $1 million in aggregate, in connection with the completion of the business combination. This is a compensatory arrangement for officers and falls squarely within Item 5.02(e) disclosure requirements.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-28
Item 1.01
Katapult entered into a Sixth Amendment to its revolving credit agreement on August 28, 2026, extending the Draw Period Termination Date from August 30, 2026 to September 30, 2026. While this is technically an amendment to an existing credit facility rather than a new issuance, amendments that extend maturity dates or modify material terms of direct financial obligations are reportable under Item 1.01 and constitute material modifications to the company's debt structure. The one-month extension suggests the company needed additional time to manage its credit facility, which is material to investors assessing the registrant's liquidity and financial obligations.
View raw filing on EDGAR →